通过抑制多巴胺多巴胺酶的催化活性来识别类化合物的模式识别
Jing Zhu1, Qing Hong Zhang1, Wen Wu Wang2
1College of Chemistry and Chemical Engineering, Qufu Normal University, Qufu, Shandong 273165, P. R. China.
Analytical chemistry
|July 17, 2024
概括
这项研究引入了一种使用多酶的新型传感器阵列,以准确识别和量化六种化物. 模式识别方法实现了100%的准确性,显示了药物查和临床应用的潜力.
科学领域:
- 生物分子工程 生物分子工程
- 分析化学 分析化学
- 生物传感器技术技术
背景情况:
- 传统的"锁钥匙"生物传感器在特定生物分子识别方面面临挑战.
- 使用半特定探头的模式识别通过分析多维信号阵列提供了一个替代方案.
- 多酶的类化合物抑制的催化活性为生物感知提供了一个独特的机制.
研究的目的:
- 设计和开发一种模式识别传感器阵列,用于区分和确定六种化物.
- 为了利用类化合物对多酶活性的差异性抑制来产生信号.
- 通过使用一种新的生物传感器方法,在化物检测中实现高精度和选择性.
主要方法:
- 三种不同的富G序列 (G-三倍体,G-四倍体,G-四倍体二次体) 与多巴胺胺体的结合,产生多酶 (G3-d-apt,GQ1-d-apt,2GQ1-d-apt).
- 通过测量六种类对三种多酶的过氧化酶活动的各种抑制作用来生成一个多维信号阵列.
- 主要组件分析 (PCA) 的应用用于数据处理和在3D空间中可视化化物模式.
主要成果:
- 传感器阵列成功地区分和分类了六种化物,在不同度中准确率为100%.
- 证明了高选择性,即使存在结构相似的类化合物.
- 目标类化合物的含量可以使用PCA. 衍生的最有影响力的歧视因子来量化.
结论:
- 开发的基于多酶的传感器阵列有效地解决了生物传感中特定识别的局限性.
- 这种模式识别策略为准确区分和确定多种化物提供了一个强大的平台.
- 该传感器阵列显示出在药物查和临床治疗监测方面的应用潜力很大.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Opioid Receptors: Overview
686
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
686
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
244
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
244
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
926
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
926


